Cadrenal Therapeutics

About:

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

Website: https://www.cadrenal.com/

Description:

Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.

Total Funding Amount:

$17.3M

Headquarters Location:

Ponte Vedra Beach, Florida, United States

Founded Date:

2022-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-11-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai